Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asako Yoritaka

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Neurobiology of Aging|February 6, 2022
Genotype-phenotype correlation of Parkinson's disease with PRKN variantsHiroyo Yoshino, Yuanzhe Li, Kenya Nishioka, et al.
NPJ Parkinson'S Disease|December 10, 2020
Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutationsMasayoshi Kano, Masashi Takanashi, Genko Oyama, et al.
BMC Neurology|May 14, 2016
A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristicsAsako Yoritaka, Takashi Abe, Chigumi Ohtsuka, et al.
BMC Neurology|March 4, 2022
Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled studyTaku Hatano, Osamu Kano, Renpei Sengoku, et al.
Scientific Reports|November 2, 2024
Digital detection of Alzheimer's disease using smiles and conversations with a chatbotHaruka Takeshige-Amano, Genko Oyama, Mayuko Ogawa, et al.
Neurology and Therapy|January 16, 2024
Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled StudyTaku Hatano, Renpei Sengoku, Hiroshi Nagayama, et al.
Clinical Parkinsonism & Related Disorders|May 5, 2025
Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson's disease: Subanalysis of the ISTRA ADJUST PDHiroshi Nagayama, Osamu Kano, Renpei Sengoku, et al.
Neurobiology of Aging|July 28, 2020
The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1Arisa Hayashida, Yuanzhe Li, Hiroyo Yoshino, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Neurobiology of Aging|February 6, 2022
Genotype-phenotype correlation of Parkinson's disease with PRKN variantsHiroyo Yoshino, Yuanzhe Li, Kenya Nishioka, et al.
NPJ Parkinson'S Disease|December 10, 2020
Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutationsMasayoshi Kano, Masashi Takanashi, Genko Oyama, et al.
BMC Neurology|May 14, 2016
A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristicsAsako Yoritaka, Takashi Abe, Chigumi Ohtsuka, et al.
BMC Neurology|March 4, 2022
Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled studyTaku Hatano, Osamu Kano, Renpei Sengoku, et al.
Scientific Reports|November 2, 2024
Digital detection of Alzheimer's disease using smiles and conversations with a chatbotHaruka Takeshige-Amano, Genko Oyama, Mayuko Ogawa, et al.
Neurology and Therapy|January 16, 2024
Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled StudyTaku Hatano, Renpei Sengoku, Hiroshi Nagayama, et al.
Clinical Parkinsonism & Related Disorders|May 5, 2025
Impact of istradefylline on motor and non-motor symptoms in patients with Parkinson's disease: Subanalysis of the ISTRA ADJUST PDHiroshi Nagayama, Osamu Kano, Renpei Sengoku, et al.
Neurobiology of Aging|July 28, 2020
The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1Arisa Hayashida, Yuanzhe Li, Hiroyo Yoshino, et al.
Pageof 4